Mark your calendars for an enlightening journey into the world of autism research! The Autism Science Foundation is thrilled to announce the 13th Day of Learning, a captivating event set to take place in the heart of New York City on March 26, 2026, at the prestigious 583 Park Ave. Get ready to immerse yourself in a day filled with groundbreaking insights and thought-provoking discussions led by renowned experts in the field. But here's where it gets controversial... Are we truly making progress in understanding and treating autism, or are we missing crucial pieces of the puzzle? Let's dive in and explore the highlights of this extraordinary day, and don't forget to share your thoughts in the comments below!
A Day of Insights and Discoveries
Understanding the Changing Autism Research Landscape
Join Josh Gordon from Columbia and the NIH as he navigates the evolving landscape of autism research. Discover how the field is adapting and expanding, offering new hope for those seeking answers. But here's the twist: How do we ensure that these advancements benefit all individuals on the autism spectrum, and what are the ethical considerations we must keep in mind?
Pushing Back: Autism Scientists Speak Out
Helen Tager-Flusberg from the Coalition for Autism Scientists at Boston University will share her insights on the challenges and triumphs of autism research. She'll shed light on the personal experiences of scientists dedicated to unraveling the mysteries of autism. But here's where it gets thought-provoking: How can we bridge the gap between scientific discoveries and real-world applications, and what role do advocacy and community engagement play in shaping the future of autism research?
The Promise of the Federal ADSI Studies
David Mandell from the University of Pennsylvania will delve into the potential of federal ADSI studies. He'll explore how these initiatives can transform our understanding of autism and pave the way for personalized treatments. But here's the question: What are the challenges and opportunities presented by these studies, and how can we ensure their success and accessibility for all?
Confirming New Autism Subtypes
John Spiro from the Simons Foundation will present groundbreaking research on confirming new autism subtypes. He'll discuss the importance of accurate diagnosis and how it can lead to more effective interventions. But here's the controversial twist: Are we over-medicalizing autism, and how might this impact the way we perceive and support individuals on the spectrum?
Prospects for Genetic Medicines
Stephan Sanders from Oxford University and UCSF will explore the exciting world of genetic medicines and their potential in treating autism. He'll discuss the latest advancements and their implications for the future of autism treatment. But here's the question: What are the ethical and practical considerations of genetic medicines, and how can we ensure their safety and effectiveness for all individuals?
Understanding Family Recurrence Beyond the First Degree
Diana Schendel from Drexel University will shed light on the complex issue of family recurrence beyond the first degree. She'll explore the genetic and environmental factors that contribute to autism and how we can better support families affected by this condition. But here's the thought-provoking question: How can we create a more inclusive and supportive environment for individuals on the autism spectrum, and what role do family dynamics play in this journey?
A Look Back: Highlights from the 12th Day of Learning
Gene Editing and Gene Therapies in Genetically-Defined Autisms
Dr. Allyson Berent from Angelman Syndrome Therapeutics will delve into the world of gene editing and gene therapies, exploring their potential in treating genetically-defined forms of autism. She'll discuss the latest advancements and their implications for the future of autism treatment. But here's the question: What are the ethical and practical considerations of gene editing, and how can we ensure its safety and effectiveness for all individuals?
Leveraging AI Tools to Characterize Autism
Dr. Robert Schultz from the University of Pennsylvania will showcase how AI tools are revolutionizing the way we characterize and understand autism. He'll discuss the latest advancements and their impact on research and clinical practice. But here's the thought-provoking question: How can we ensure that AI tools are accessible and beneficial to all individuals, and what are the ethical considerations we must keep in mind?
The Critical Role of Families in Autism Research Utilizing Post-Mortem Brain Tissue
Dr. David Amaral from the University of California, Davis, will explore the critical role of families in autism research, particularly in the use of post-mortem brain tissue. He'll discuss the importance of family involvement and how it can advance our understanding of autism. But here's the question: What are the ethical considerations of using post-mortem brain tissue, and how can we ensure that families are respected and supported throughout the research process?
Organoids and Assembroids for Personalized Profound Autism Treatment
Dr. Rebeca Levy from Stanford University will present the exciting world of organoids and assembloids, and how they can be used to develop personalized treatments for profound autism. She'll discuss the latest advancements and their implications for the future of autism treatment. But here's the thought-provoking question: What are the ethical and practical considerations of using organoids and assembloids, and how can we ensure their safety and effectiveness for all individuals?
Utilizing AI to Understand Early Development in Infants
Dr. Elena Tenenbaum from Duke University will explore the potential of AI in understanding early development in infants, particularly in the context of autism. She'll discuss the latest advancements and their impact on early intervention. But here's the question: What are the ethical considerations of using AI in early development, and how can we ensure that it is used responsibly and effectively?
Using Wearable Devices to Reduce Severe Behaviors in Students with Profound Autism
Dr. Heather Nuske from the University of Pennsylvania will showcase how wearable devices are being used to reduce severe behaviors in students with profound autism. She'll discuss the latest advancements and their impact on education and support. But here's the thought-provoking question: What are the ethical considerations of using wearable devices in education, and how can we ensure that they are used responsibly and effectively?
So, are you ready to join us on this extraordinary journey into the world of autism research? We can't wait to see you there! Don't forget to share your thoughts and insights in the comments below. Together, let's explore the mysteries of autism and create a brighter future for all individuals on the spectrum.
